Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain

by Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A
Published 2018-11-01

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

by García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sanjurjo Sáez M, Martín M, López-Fernández LA
Published 2018-10-01